COVID-19: the tipping point for digital transformation in biopharma
Digital transformation in sales, marketing and medical has generally been slow in life sciences companies. Digital budgets have nudged up only slowly (and were mostly spent on technology), while skill levels have remained low. Indeed, well below 10% fully believe their staff are well trained in digital (2018-2020 Across Health Multichannel Maturometer):
With the arrival of COVID-19, the offline customer engagement model (which represented 95% of commercial budgets vs 5% for digital) came to a grinding halt. At the same time, customer expectations increased, with close to 60% of HCPs finding digital services by pharma important – but only 36% are satisfied:
Capability-building at scale in the next normal
In other industries, which often were already ahead, COVID-19 further increased the speed of change. Indeed, as Satya Nadella, the CEO of Microsoft, said in April 2020: “We saw 2 years of digital transformation in 2 months”. In the same vein, Deloitte observed that the working from home trend had accelerated by 5 years.
Similarly, life sciences companies need to boost their customer engagement teams’ capabilities quickly (skills and knowledge, powered by a positive mindset) – across all customer-facing teams (sales, marketing, medical, access, patient affairs, etc.), all over the world. After 30 years, the tipping point has been reached – and it should lead to a fast acceleration, enabled by a quick ramp-up of capabilities:
The only way to achieve skill-building at scale is through a strong focus on technology-enabled learning, blended with selective human intervention (coaching, live training, etc).
Across Health has a deep expertise in both traditional capability-building as well as online learning. For instance, during the COVID-19 crisis, it opened up its 15 eLearning modules for free to the industry, with over 3,500 participants and over 20,000 courses taken.
By summer 2020, Across Health is launching SCALA, a highly interactive multidisciplinary capability-building platform for omnichannel engagement excellence in biopharma. In the summer release, the following topics will be covered:
To further optimize the learning and user experience, the following features will be launched before the end of 2020:
Across Health will continue to develop the platform, by adding and updating content, offering new services and launching extra value-added platform features.
Want more information?
In the initial summer 2020 release, SCALA will be offered at the company level – i.e. customers get their own dedicated instance. For more information, please contact us.